Cargando…

Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating

Approximately two-thirds of US children and adolescents have either obesity or overweight status, with almost 24% of adolescents (ages 12–19 years) afflicted with severe obesity, defined as >1.2 × the 95th BMI percentile for age/gender. Despite the increasing disproportionate rise in severe or ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Gitanjali, O’Hara, Valerie, Browne, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406487/
https://www.ncbi.nlm.nih.gov/pubmed/30720744
http://dx.doi.org/10.3390/children6020022
_version_ 1783401315325444096
author Srivastava, Gitanjali
O’Hara, Valerie
Browne, Nancy
author_facet Srivastava, Gitanjali
O’Hara, Valerie
Browne, Nancy
author_sort Srivastava, Gitanjali
collection PubMed
description Approximately two-thirds of US children and adolescents have either obesity or overweight status, with almost 24% of adolescents (ages 12–19 years) afflicted with severe obesity, defined as >1.2 × the 95th BMI percentile for age/gender. Despite the increasing disproportionate rise in severe or extreme childhood obesity, many children in weight management programs do not achieve a healthy weight. Most often, these patients will go on to require metabolic and bariatric surgery (MBS), but challenges and limitations may prohibit MBS on adolescents. Thus, tertiary care pediatric weight management centers are compelled to treat select pediatric obesity subtypes presenting with disease progression and disability with the available adult FDA-approved therapeutic modalities, specifically pharmacotherapy, in order to alleviate the disease state and provide relief to the patient. Here, we describe a case of severe pediatric obesity where a dedicated multidisciplinary pediatric weight management team at a tertiary care center utilizes a progressive pharmacotherapeutic approach with enormous benefits to the patient, highlighting the urgent gap and clinical care needs of this special population niche of severe adolescent obesity.
format Online
Article
Text
id pubmed-6406487
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64064872019-03-13 Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating Srivastava, Gitanjali O’Hara, Valerie Browne, Nancy Children (Basel) Case Report Approximately two-thirds of US children and adolescents have either obesity or overweight status, with almost 24% of adolescents (ages 12–19 years) afflicted with severe obesity, defined as >1.2 × the 95th BMI percentile for age/gender. Despite the increasing disproportionate rise in severe or extreme childhood obesity, many children in weight management programs do not achieve a healthy weight. Most often, these patients will go on to require metabolic and bariatric surgery (MBS), but challenges and limitations may prohibit MBS on adolescents. Thus, tertiary care pediatric weight management centers are compelled to treat select pediatric obesity subtypes presenting with disease progression and disability with the available adult FDA-approved therapeutic modalities, specifically pharmacotherapy, in order to alleviate the disease state and provide relief to the patient. Here, we describe a case of severe pediatric obesity where a dedicated multidisciplinary pediatric weight management team at a tertiary care center utilizes a progressive pharmacotherapeutic approach with enormous benefits to the patient, highlighting the urgent gap and clinical care needs of this special population niche of severe adolescent obesity. MDPI 2019-02-04 /pmc/articles/PMC6406487/ /pubmed/30720744 http://dx.doi.org/10.3390/children6020022 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Srivastava, Gitanjali
O’Hara, Valerie
Browne, Nancy
Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
title Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
title_full Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
title_fullStr Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
title_full_unstemmed Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
title_short Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
title_sort use of lisdexamfetamine to treat obesity in an adolescent with severe obesity and binge eating
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406487/
https://www.ncbi.nlm.nih.gov/pubmed/30720744
http://dx.doi.org/10.3390/children6020022
work_keys_str_mv AT srivastavagitanjali useoflisdexamfetaminetotreatobesityinanadolescentwithsevereobesityandbingeeating
AT oharavalerie useoflisdexamfetaminetotreatobesityinanadolescentwithsevereobesityandbingeeating
AT brownenancy useoflisdexamfetaminetotreatobesityinanadolescentwithsevereobesityandbingeeating